Celea Therapeutics

“Leal Therapeutics raised $30 million in a Series A extension with investment from Eli Lilly, OrbiMed and Newpath Partners.”

“Raised a $180 million round…investors included RA Capital Management, Leaps by Bayer.”

“Celea Therapeutics, a biopharma focused on treatments for respiratory diseases, raised a $180 million round.”